Thomas Carell

25.0k total citations · 4 hit papers
379 papers, 18.6k citations indexed

About

Thomas Carell is a scholar working on Molecular Biology, Organic Chemistry and Materials Chemistry. According to data from OpenAlex, Thomas Carell has authored 379 papers receiving a total of 18.6k indexed citations (citations by other indexed papers that have themselves been cited), including 339 papers in Molecular Biology, 51 papers in Organic Chemistry and 51 papers in Materials Chemistry. Recurrent topics in Thomas Carell's work include DNA and Nucleic Acid Chemistry (127 papers), Advanced biosensing and bioanalysis techniques (96 papers) and Epigenetics and DNA Methylation (76 papers). Thomas Carell is often cited by papers focused on DNA and Nucleic Acid Chemistry (127 papers), Advanced biosensing and bioanalysis techniques (96 papers) and Epigenetics and DNA Methylation (76 papers). Thomas Carell collaborates with scholars based in Germany, United States and Switzerland. Thomas Carell's co-authors include Markus Müller, Guido H. Clever, Philipp M. E. Gramlich, Johannes Gierlich, Martin Münzel, Mirko Wagner, Corinna Kaul, Daniel Globisch, Glenn A. Burley and Christian T. Wirges and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Thomas Carell

374 papers receiving 18.4k citations

Hit Papers

Tissue Distribution of 5-... 2007 2026 2013 2019 2010 2007 2016 2017 200 400 600

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Thomas Carell 15.2k 3.2k 2.0k 1.5k 1.3k 379 18.6k
Shankar Balasubramanian 32.9k 2.2× 2.4k 0.8× 1.6k 0.8× 1.1k 0.7× 1.6k 1.3× 378 38.8k
Alice Y. Ting 14.1k 0.9× 4.6k 1.4× 2.1k 1.0× 770 0.5× 478 0.4× 128 21.4k
Daniel Herschlag 19.6k 1.3× 1.6k 0.5× 2.4k 1.2× 550 0.4× 652 0.5× 291 23.3k
Hiroshi Sugiyama 16.2k 1.1× 2.8k 0.9× 1.8k 0.9× 478 0.3× 696 0.5× 777 21.3k
Douglas C. Rees 13.8k 0.9× 2.0k 0.6× 5.0k 2.5× 1.4k 0.9× 267 0.2× 231 27.2k
Peter B. Dervan 21.5k 1.4× 4.5k 1.4× 1.2k 0.6× 415 0.3× 593 0.5× 358 24.7k
Demetrios Papahadjopoulos 18.2k 1.2× 2.0k 0.6× 1.2k 0.6× 359 0.2× 757 0.6× 178 26.2k
M.R. Sawaya 21.3k 1.4× 1.2k 0.4× 4.4k 2.1× 683 0.5× 388 0.3× 243 27.9k
Thomas M. Jovin 11.8k 0.8× 1.0k 0.3× 2.4k 1.2× 495 0.3× 345 0.3× 298 19.4k
Young‐Tae Chang 9.8k 0.6× 3.7k 1.1× 6.2k 3.0× 469 0.3× 600 0.5× 436 21.7k

Countries citing papers authored by Thomas Carell

Since Specialization
Citations

This map shows the geographic impact of Thomas Carell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Carell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Carell more than expected).

Fields of papers citing papers by Thomas Carell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Carell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Carell. The network helps show where Thomas Carell may publish in the future.

Co-authorship network of co-authors of Thomas Carell

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Carell. A scholar is included among the top collaborators of Thomas Carell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Carell. Thomas Carell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Carell, Thomas, et al.. (2024). Gradual evolution of a homo-l-peptide world on homo-d-configured RNA and DNA. Chemical Science. 15(35). 14171–14176. 3 indexed citations
2.
Carell, Thomas, et al.. (2024). Step‐by‐Step Towards Biological Homochirality – from Prebiotic Randomness To Perfect Asymmetry. Chemistry - An Asian Journal. 20(1). e202401074–e202401074. 2 indexed citations
3.
Karousi, Paraskevi, Martina Samiotaki, Manousos Makridakis, et al.. (2023). 3′-tRF-CysGCA overexpression in HEK-293 cells alters the global expression profile and modulates cellular processes and pathways. Functional & Integrative Genomics. 23(4). 341–341. 2 indexed citations
4.
Wiedemann, Stefan, et al.. (2023). An Aminoisoxazole‐Based Proto‐RNA. SHILAP Revista de lepidopterología. 1(3). 1 indexed citations
5.
Linder, Andreas, Daniel Nixdorf, Ignazio Piseddu, et al.. (2023). Sting Activation Improves T-Cell Engaging Immunotherapy of Acute Myeloid Leukemia. Blood. 142(Supplement 1). 2055–2055. 1 indexed citations
6.
Crisp, Antony L., et al.. (2023). Orthogonal End Labelling of Oligonucleotides through Dual Incorporation of Click‐Reactive NTP Analogues. ChemBioChem. 25(1). e202300701–e202300701. 1 indexed citations
7.
Müller, Felix, et al.. (2023). Loading of Amino Acids onto RNA in a Putative RNA‐Peptide World. Angewandte Chemie International Edition. 62(21). e202302360–e202302360. 11 indexed citations
8.
Böhmer, Daniel, David Drexler, Stefan Bauernfried, et al.. (2022). Novel Poxin Stable cGAMP‐Derivatives Are Remarkable STING Agonists. Angewandte Chemie International Edition. 61(40). e202207175–e202207175. 21 indexed citations
9.
Drexler, David, et al.. (2022). Chemical Synthesis of the Fluorescent, Cyclic Dinucleotides cthGAMP. ChemBioChem. 23(8). e202200005–e202200005. 4 indexed citations
10.
Carell, Thomas, et al.. (2022). 1 H NMR Chemical Exchange Techniques Reveal Local and Global Effects of Oxidized Cytosine Derivatives. ACS Physical Chemistry Au. 2(3). 237–246. 6 indexed citations
11.
Müller, Felix, et al.. (2022). A prebiotically plausible scenario of an RNA–peptide world. Nature. 605(7909). 279–284. 96 indexed citations
12.
Fugger, Kasper, Ilirjana Bajrami, Mariana Silva dos Santos, et al.. (2021). Targeting the nucleotide salvage factor DNPH1 sensitizes BRCA -deficient cells to PARP inhibitors. Science. 372(6538). 156–165. 91 indexed citations
13.
Carell, Thomas, et al.. (2021). Biomimetic Iron Complex Achieves TET Enzyme Reactivity**. Angewandte Chemie. 133(39). 21627–21633. 2 indexed citations
14.
Carell, Thomas, et al.. (2021). Biomimetic Iron Complex Achieves TET Enzyme Reactivity**. Angewandte Chemie International Edition. 60(39). 21457–21463. 14 indexed citations
15.
Traube, Franziska R., Sarantos Kostidis, Katharina Iwan, et al.. (2021). Redirected nuclear glutamate dehydrogenase supplies Tet3 with α-ketoglutarate in neurons. Nature Communications. 12(1). 4100–4100. 19 indexed citations
16.
Romanelli, Marco, Vishal Kumar Jaiswal, Thomas Carell, et al.. (2021). Unified Description of Ultrafast Excited State Decay Processes in Epigenetic Deoxycytidine Derivatives. The Journal of Physical Chemistry Letters. 12(45). 11070–11077. 9 indexed citations
17.
Okamura, Hidenori, et al.. (2019). Proto‐Urea‐RNA (Wöhler RNA) Containing Unusually Stable Urea Nucleosides. Angewandte Chemie. 131(51). 18864–18869. 6 indexed citations
18.
Edupuganti, Raghu Ram, Simon Geiger, Rik G.H. Lindeboom, et al.. (2017). N6-methyladenosine (m6A) recruits and repels proteins to regulate mRNA homeostasis. Nature Structural & Molecular Biology. 24(10). 870–878. 427 indexed citations breakdown →
19.
Alt, Aaron, Katja Lammens, Claudia Chiocchini, et al.. (2007). Bypass of DNA Lesions Generated During Anticancer Treatment with Cisplatin by DNA Polymerase η. Science. 318(5852). 967–970. 172 indexed citations
20.
Mees, Alexandra, Tobias Klar, Petra Gnau, et al.. (2004). Crystal Structure of a Photolyase Bound to a CPD-Like DNA Lesion After in Situ Repair. Science. 306(5702). 1789–1793. 308 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026